Coronavirus (COVID-19)

Find our resources or medicines guidance summaries. Use for the government response, and for health information.

Hide message

Aripiprazole in bipolar disorder (amended)

This review summarises the data on safety, efficacy and cost-effectiveness of aripiprazole in bipolar I disorder, alongside recommendations on its use issued by the SMC…
Filters (1) Toggle